All blog posts
Total 7 results for
Showing 7 out of 7 results
06 December 2023
Competition law and biosimilars: Time for a new approach or not yet?
23 November 2023
CMA issues guidance permitting drugs companies to work together on Combination Therapies
15 August 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
09 February 2023
Competition law developments in the pharma sector – 2022 round-up and what to expect in 2023
09 February 2022
Competition law in the pharma sector – Developments and what’s to come in 2022
16 February 2021
Excessive pricing: EU Commission accepts Aspen’s drug pricing commitments
27 October 2020
Pharmaceutical sector under increased antitrust scrutiny in the UK
Showing 7 out of 7 results
Key contacts
Kyriakos Fountoukakos
Managing Partner, Competition/Antitrust, Regulation and Trade, Brussels
Veronica Roberts
Partner, Head of Competition/Antitrust, Regulation and Trade, UK, London
Linda Evans
Managing Partner, Competition Regulation and Trade, Asia and Australia, Sydney
Adelaide Luke
Partner, Head of Competition, Asia, Hong Kong
Jean Meijer
Managing Partner, Johannesburg Office, Johannesburg
Kristien Geeurickx
Knowledge Counsel, London